BIOT

Stem Cells & Regenerative Medicine
J. Latone, G. M. Thurber, I. R. Wheeldon, Organizers
P. Apostolidis, Y. Kim, Organizers, Presiding
2:00 228. CD264: A cell-surface marker for an aging population of mesenchymal stem cells. S. Madsen, K.
Russell, A. Tucker, B. Bunnell, K. OConnor
2:20 229. Regenerative medical bioadhesive based on photo-curable mussel adhesive protein hydrogel. E.
Jeon, B. Choi, B. Hwang, Y. Yang, G. Jung, H.J. Cha
2:40 230. Modeling the blood-brain barrier using human pluripotent stem cells. E. Shusta
3:20 Intermission.
3:40 231. Cell-derived microparticles for cell & gene therapy: The case of megakaryocytic microparticles. J.
Jiang, C. Kao, E.T. Papoutsakis
4:00 232. High yield in vitro expansion of cancer stem cells / tumor initiating cells. S.G. Tilson, E.M. Haley,
Y. Kim
4:20 233. Scalable hepatic differentiation of human endodermal cells from pluripotent stem cell. D. Chau, K.
Ortiz, W. Hu
4:40 234. Extracellular matrix mimetic chemical and physical cues for promoting human mesenchymal stem
cell tenogenic gene expression. M. Rehmann, A.M. Kloxin
Westin San Diego
Crystal I
Biosimilars
Challenges in Demonstrating Analytical Biosimilarity
Section E
J. Myers, K. Sampathkumar, Organizers
B. Bernat, A. Fotopoulos, Organizers, Presiding
2:00 Introductory Remarks.
2:20 235. Characterization and quantitative comparison of remicade and its biosimilar remsima. A.
Schwendeman
2:40 236. Using critical quality attributes in the development of biosimilars. B. Bernat, J. TerWee
3:00 237. Higher order structure analysis using hydrogen deuterium exchange mass spectrometry (HDX MS)
and differential scanning calorimetry (DSC). C.F. Quinn
3:20 Intermission.